SIMS ANDREW JOHN HUGH MACINTYRE (Chief Financial Officer) purchased 601.5% of their position (4.90K shares) of PLUS THERAPEUTICS, INC. on the open market
Open‑market purchase worth $10.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/10/2024ACC: 0000950170-24-057456
Officer· Chief Financial Officer
Since Feb 2020
+14.71K
Net shares
Net buyer
$10.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
14.71K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.90K
Price / share
$2.04
Trade value
$10K
% of position
601.5%
5/8/2024
815.00→5.72K
Total
Net shares
+4.90K
Net value
$10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/8/2024 | P · Purchase | +4.90K | $2.04 | $10K | 601.5% | 815.00 | 5.72K |
| Total | +4.90K | $10K | ||||||
Derivative Transactions1
Warrants (Right to buy)
Direct
Converts to
Common Stock Warrants
9.80K shares
Shares
+9.80K
Strike price
1.79
Held after
9.80K
Exercisable
—
5/8/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants (Right to buy) Direct | Common Stock Warrants9.80K shares | 5/8/2024 | A · Award | +9.80K | 1.79 | — | 9.80K |